Skip to main content
. 2019 Sep 4;17(3):1559325819872583. doi: 10.1177/1559325819872583

Figure 6.

Figure 6.

Cytotoxicity of blank nanoparticles at different concentrations. BT474 cells were treated with blank PPLNs and blank eTmab-PPLNs at the concentrations of 5, 20, 50, and 200 μg/mL for 48 hour, n = 6. eTmab-PPLNs, electrostatically conjugated trastuzumab-bearing poly (d, l-lactide-co-glycolide)/polyethylenimine/lipid nanoparticles; PPLNs, poly (d, l-lactide-co-glycolide)/polyethylenimine/lipid nanoparticles.